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a-Synuclein
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Higher cellular levels of the protein a-synuclein directly contribute to Parkinson’s disease, and increasing a-syn-
uclein degradationmay slow disease progression. Abeywardana et al. demonstrate that the nine different sites of
monoubiquitination on a-synuclein have different effects on its proteasomal degradation.Misfolded tRNA behind the Bacterial Baldness
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Streptomyces calvus has long been known to have a ‘‘bald,’’ nonsporulating
phenotype. Kalan et al. reveal that the bald phenotype arises from a point
mutation in the bldA gene that encodes a misfolded tRNA molecule. With a
correct bldA gene, sporulation is restored, and a cryptic polyketide is
produced.What Governs Type II Polyketide Ketoreductase
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Type II polyketides are a broad group of natural products with broad range of biological activities. Javidpour et al.
examine molecular features that govern the reduction regiospecificity of type II polyketide by ketoreductase (KR)
by structural and biochemical analyses.A Different Kind of Diuretics
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Kidney urea transporter UT-A1 inhibitors may be useful as a novel class of diuretics (‘‘urearetics’’). Esteva-Font
et al. develop an efficient HTS for identification of UT-A1 inhibitors. Structure-activity analysis, functional studies,
and docking revealed features important for UT-A1-selectivity.Chemical Chaperones that Modulate Bacterial
Amyloid Formation
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Amyloids are the hallmark of many neurodegenerative diseases. Interest-
ingly, amyloids also provide structural integrity to bacterial biofilms. Ander-
sson et al. report several compounds that act as modulators of amyloid
formation, with both antiamyloid and proamyloid characteristics.Chemistry & Biology 20, October 24, 2013 ª2013 Elsevier Ltd All rights reserved v
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Qian et al. report development of short monoanionic phosphothreonine
(pThr)-containing peptides that bind to the polo-like kinase 1 (Plk1) polo-
box domain (PBD) with low nanomolar affinity in extracellular assays. They
exhibit high antimitotic efficacies in whole cell assays at micromolar concen-
trations.Cobamides and CobT Enzyme: Part One
PAGE 1265The cobamide cofactors, including vitamin B12, have structural variability in the lower ligand. Crofts et al. demon-
strate that cobamide-producing bacteria limit the attachment of potential lower ligands because of substrate
specificity in the CobT enzyme, enabling bacteria to produce only cobamides they can use.Cobamides and CobT Enzyme: Part Two
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Vitamin B12 and other cobamides differ in their lower ligands. Hazra et al. show that 5,6- dimethylbenzimidazole
(the lower ligand of B12) is the preferred substrate for the lower ligand activation enzyme CobT, suggesting that
cobamides produced by bacteria in the environment and in pure culture may differ.Potent Peptidomimetics as Asset When on a Defensive
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In an era where novel antibiotic agents are urgently needed, Jahnsen et al. demonstrate that a simple host de-
fense peptidomimetic, HDM-4, is capable of mobilizing the immune response and killing clinically important
Gram-negative pathogens. Thus, it represents a promising antibiotic lead compound.vi Chemistry & Biology 20, October 24, 2013 ª20Resource: Mmmm. mPapaya1!
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Coral-derived fluorescent proteins, widely used for imaging of proteins
in live cells, are tetrameric, which may interfere with the function of the
imaged protein. Hoi et al. describe the engineering of a monomeric
coral-derived yellow fluorescent protein, mPapaya1, with an atypical
chromophore structure.13 Elsevier Ltd All rights reserved
